Prognostic impact of hospital readmissions after primary percutaneous coronary intervention

Archives of Internal Medicine

Volumn 171, Issue 21, 2011, Pages 1948-1949

  Campo, Gianluca ^a,b   Saia, Francesco ^c   Guastaroba, Paolo ^d   Marchesini, Jlenia ^a,b   Varani, Elisabetta ^e   Manari, Antonio ^f   Ottani, Filippo ^g   Tondi, Stefano ^h   De Palma, Rossana ^d   Marzocchi, Antonio ^c  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Area Rischio Infettivo   (Italy)

^e SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g MORGAGNI PIERANTONI HOSPITAL   (Italy)

^h Ospedale di Baggiovara (Mo)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIAC RESYNCHRONIZATION THERAPY; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; HEART GRAFT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIOFREQUENCY ABLATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 82455206030     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.536     Document Type: Article

References (9)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20. (Pubitemid 36050955)
2. Campo G, Saia F, Percoco G, et al. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry. Int J Cardiol. 2010;140(2):154-160.
3. Saia F, Piovaccari G, Manari A, et al. Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry. EuroIntervention. 2009;5(1):57-66.
4. Marzocchi A, Saia F, Piovaccari G, et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation. 2007;115(25):3181-3188. (Pubitemid 47012232)
5. Ducrocq G, Wallace JS, Baron G, et al. REACH Investigators. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J. 2010;31(10):1257-1265.
6. Spencer FA, Meyer TE, Gore JM, Goldberg RJ. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002;105(22):2605-2610. (Pubitemid 34596036)
7. Wiviott SD, Braunwald E, McCabe CH, et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001-2015. (Pubitemid 350106708)
8. Wallentin L, Becker RC, Budaj A, et al. PLATO Investigators. Ticagrelor vs clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
9. Spencer FA, Moscucci M, Granger CB, et al. GRACE Investigators. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007;116(24):2793-2801. (Pubitemid 350291221)